<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">DCTN5 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>DCTN5</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>DCTN5</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=DCTN5" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">6 edges</a></td>
</tr>
</table>
Dctn5 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">DCTN5 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>DCTN5</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>DCTN5</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=DCTN5" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">6 edges</a></td>
</tr>
</table>
Dctn5 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
[DCTN5](/genes/dctn5) encodes dynactin subunit 5 (historically p25), a pointed-end component of the [dynactin complex](/proteins/dynactin-complex) that supports cargo engagement and efficient cytoplasmic dynein transport.[@schroer2012][@eckley1999][@lau2021] In [neurons](/entities/neurons), this system is central to long-range retrograde trafficking of endosomes, autophagosomes, and stress-response cargoes along microtubules.[@zhang2011][@qiu2018]
For neurodegeneration, the strongest evidence is at pathway level: dynein-dynactin transport failure is repeatedly linked to selective neuronal vulnerability in [Amyotrophic Lateral Sclerosis (ALS)](/diseases/amyotrophic-lateral-sclerosis)))))))))))), [Parkinson's Disease](/diseases/parkinsons-disease), and related disorders, while direct human genotype-phenotype evidence specific to DCTN5 remains comparatively limited.[@yu2018][@kumakozakiewicz2013][@millecamps2013]
DCTN5 is located on chromosome 16p12.2 and is broadly expressed, including in CNS tissues with high transport demand.[@ncbi] Like other dynactin genes, expression pattern and complex stoichiometry suggest a constitutive support role rather than a neuron-subtype-restricted signaling role. In practice, this means DCTN5 effects are expected to emerge most strongly in neurons with long axons and high baseline trafficking loads.
Dynactin is built around an Arp1 filament with specialized barbed-end and pointed-end modules. DCTN5 (p25) sits in the pointed-end module with p27 (DCTN6), p62 (DCTN4), and Arp11, where it contributes to adaptor-facing interfaces and cargo targeting behavior.[@schroer2012][@eckley1999][@lau2021]
Mechanistically relevant functions associated with p25/DCTN5 include:
Multiple human and model-system studies support axonal transport failure as a convergent mechanism in neurodegenerative syndromes, with dynactin deficiency producing motor-neuron-predominant pathology and ALS-like phenotypes.[@yu2018][@kumakozakiewicz2013][@millecamps2013]
Because DCTN5 is embedded in the pointed-end cargo-targeting module, altered DCTN5 dosage or assembly compatibility is mechanistically expected to reduce transport efficiency and stress resilience, particularly in long projecting neurons.[@schroer2012][@zhang2011][@qiu2018]
Compared with [DCTN1](/genes/dctn1), direct DCTN5-centric human pathogenic variant evidence in major adult neurodegenerative diagnoses is sparse. This is best treated as an evidence gap rather than evidence of no effect, and it motivates targeted genetics plus functional perturbation studies.
Priority experiments for clarifying DCTN5 biology in neurodegeneration:
The study of Dctn5 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
The following diagram shows the key molecular relationships involving DCTN5 Gene discovered through SciDEX knowledge graph analysis: